The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

Thu, 17th Dec 2020 22:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

SolGold PLC - Australian gold and copper mining company with operations in Ecuador and Australia - Says first drill hole at Tandayama-America, at the Cascabel project, discovers highly mineralised system. The mineralisation intersected at Tandayama-America is very similar to the "QD10" quartz-diorite source intrusion at the company's flagship Alpala project which lies only 3 kilometres to south. The QD10 source intrusion at Alpala is almost wholly responsible for the presence of the high-grade core of the deposit which has 442 million tonnes at 1.40% copper equivalent containing 3.8 million tonnes copper and 12.3 million ounces gold in the measured plus indicated categories. Chief Executive Nicholas Mather says: "This discovery will impact significantly on the upside for the Alpala development. The quartz diorite host with close similarities to the richly endowed QD10 intrusion at Alpala is indeed an encouraging element." Separately, significant minority of shareholders vote against reappointment of board members Mather and Clare.

----------

Bluefield Solar Income Fund Ltd - investment company focused on the acquisition and long term management of a portfolio of low carbon assets in the UK - Notes significant minority of shareholders vote against option for directors to issue or sell up to 10% of company's share at annual general meeting. Resolution was not passed as 27% vote against. Says it will continue to engage with shareholders to understand the reasons for the votes.

----------

TMT Investments PLC - venture capital company investing in high-growth technology companies - Says portfolio company Bolt, a ride-hailing and food delivery company has successfully raised EUR150 million in an equity finance round led by D1 Capital Partners. The transaction represents a substantial valuation uplift of approximately USD14.1 million, or 64%, in the value of TMT's investment in Bolt, compared to the previous amount as of June 30.

----------

JPEL Private Equity Ltd - investment company focused on private equity partnerships and direct investments in Europe, North America and Asia - Completes transfer of its indirect minority interest in MBI Holding Inc. The company's indirect interest in MBI is its largest investment representing approximately USD65.0 million of its NAV. The transaction is being completed at an 8.5% premium to that valuation. Has also returned its eighth capital distribution in respect of the company's US dollar Equity Share class. Will return USD75 million to US dollar Equity Share class holders. Redemption proceeds will be comprised of existing cash on JPEL's balance sheet and proceeds from the sale of the indirect interest in MBI.

----------

Caledonia Mining Corp PLC - Zimbabwe-focused gold producer - Enters into an option agreement over Glen Hume, including a further option agreement in respect of another area in Zimbabwe. This option agreement gives the company the exclusive right to explore and subsequently, if exploration is successful and at its sole discretion, acquire the mining claims over an area known as Connemara North, a property which, like Glen Hume, is situated in the Gweru mining district in the Zimbabwe Midlands that has historically produced significant quantities of gold. The total is an initial payment of USD300,000, followed by a further payment of USD5 million which will be payable if Caledonia decides to exercise its right to acquire the mining claims.

----------

SIMEC Atlantis Energy Ltd - renewable energy company - Chief Executive Tim Cornelius says 2021 to be "exciting". He adds: "Today, we have announced that we have effectively put in place a war chest which will allow us to capitalise on new opportunities next year. Further, this facility is a prudent way of ensuring that we have access to a pool of capital now and are not left second guessing what will happen with equity capital markets post Brexit in 2021. To be working with a US institutional investor for the first time since our long-standing relationship with Morgan Stanley demonstrates the appetite new investors have for exposure to our flagship projects."

----------

Kavango Resources PLC - exploration company targeting mineral deposits in Botswana - Offers exploration update for its LVR project in the Kalahari Copperbelt. Chief Executive Michael Foster says: "The LVR joint venture is rapidly turning into a significant copper/silver exploration project for Kavango. We were extremely fortunate to secure this earn-in arrangement when we did at the start of this year. The proximity of one of the licences to the major metal discoveries at T3 & A4 (Sandfire), and the known regional geological structures, make these licences highly prospective. Now that we have started exploration work and have already identified zinc anomalies in the local soils, we are increasingly encouraged by the potential here. We look forward to undertaking airborne geophysical surveys early in the new year."

----------

ReNeuron Group PLC - developer of cell-based therapeutics - Says US Patent & Trademark Office has completed its examination of patent application 15/613,030, entitled: "Low oxygen culture conditions for maintaining retinal progenitor cell multipotency", and has issued a notification of allowance for the issuance of a patent. "This important allowed patent protects both the composition of ReNeuron's hRPC cell-based therapeutic candidate and its method of use. As such, it constitutes a principal layer of intellectual property pertaining to the company's retinal disease programme," company adds.

----------

Trident Royalties PLC - AIM-listed mining royalty and streaming company - Says technical update for the Warrawoona Royalty over exploration licence E45/3381, which forms part of the broader Warrawoona gold project, owned and operated by Sydney-listed Calidus Resources Ltd, has successfully passed a number of important development and finance milestones. Calidus has stated that it is fully funded to commence gold production at the project, scheduled in early 2022, following the completion of a definitive feasibility study in September 2020. Trident has a binding agreement to acquire a 1.5% net smelter royalty over the eastern part of the planned Warrawoona mine.

----------

Trinity Exploration & Production PLC - oil and gas company focused solely on Trinidad & Tobago - Signs memorandum of understating with The National Gas Co of Trinidad and Tobago Ltd, to explore and develop new projects to enable energy transition in Trinidad and, potentially, in the wider Caribbean and Latin America. "This collaborative initiative is part of Trinity's and NGC's wider growth strategies; aiming to derive further value from existing licences, to establish a broader portfolio of energy assets via acquisition and partnerships, and to challenge and further reduce carbon output," company adds.

----------

Tirupati Graphite PLC - London based flake graphite company, with primary mining and processing projects in Madagascar and India - Successfully develops and commercialises technology to manufacture flame retardant polyurethane foam for use in manufacture of the FRF at its Patalganga plant in India. "The FRC is being produced to the latest European approved standard aimed at protecting passengers and staff against onboard fire incidents on railway vehicles and defines the requirements for the fire behaviour of materials and components including the foam used in passenger coach seats and berths, a standard which has recently been adopted by the Indian Railways," company adds. Tirupati has received an initial procurement order of FRC at USD4,000 per million tonnes, enabling the Indian manufacturer to manufacture enough FRF for 50 carriages with further sales expected on a continued basis.

----------

Global Petroleum Ltd - oil and gas, upstream exploration company presently focused on Africa and the Mediterranean - Says interpretation of the seismic data recently acquired, notably the 2D seismic data over the relatively under-explored eastern part of PEL0094, Block 2011A, is progressing well. The company expects the interpretation of this data to enhance significantly the prospectivity already identified in this area. Given the progress made, the company expects to be able to publish an updated prospective resources estimate for PEL0094 in the latter part of January.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Jan 2010 13:48

Sector movers: Drug sector off colour

The pharmaceuticals sector fell back after AstraZeneca posted a 10% rise in fourth quarter earnings, but predicted 2010 revenues would be hit by the loss of exclusive rights to sell certain drugs. The company is also planning to cut 8,000 jobs from its global workforce of 63,000. While Astra falls

Read more
28 Jan 2010 11:25

Small caps round-up: Xcite, ReNeuron, CPL Resources

Shares in Xcite Energy jumped after the oil group said its subsidiary Xcite Energy Resources has concluded an agreement with BP subsidiary BP Oil International to market and sell Xcite's crude oil from the Bentley field in the North Sea. ReNeuron group climbed after the stem cell developer said Pha

Read more
11 Jan 2010 16:41

London close: Footsie gives up gains

The leading share index gave up early gains to finish only slightly higher as euphoria over strong trade figures from China in December gave way to renewed fears over recovery prospects. China's December imports jumped by 55.9% from the same month the previous year, while exports were 17.7% higher

Read more
11 Jan 2010 14:16

London afternoon: Stocks back on the climb

Leading shares, which had been surrendering early gains at the end of the morning, picked up again over the lunch time session, helped by expectations of a firm start by Wall Street. In the absence of much in the way of corporate events to attract attention, traders have been focused on broker note

Read more
11 Jan 2010 08:44

ReNeuron poised for stroke treatment trials

Stem cell therapy group ReNeuron said it is on track to start human trials of its flagship treatment ReN001 for disabled stroke patients in the first quarter of this year. ReNeuron said it has submitted extra data for the UK's Gene Therapy Advisory Committee. If a successful review of the data is r

Read more
26 Nov 2009 14:45

Small caps round-up: Hampson Industries, Bezant, Tangent Comms...

Aerospace and engineering group Hampson Industries reported a 32% slump in first half profit before tax to £11m on revenue down 12% to £97m. "Although the immediate outlook for our core markets remains uncertain, present customer indications and the scale of new work in the pipeline all point to a

Read more
16 Nov 2009 11:54

Small caps round-up: Ocean Wilsons, Fortune Oil, Freshwater...

PR and marketing group Freshwater's profits fell sharply last year, but the fourth quarter saw an improvement that has continued into the current year. Pre-tax profit fell to £0.24m from £1.17m, on sales of £9.1m down from £9.5m. "Profitability improved in the second half, and we have gone into th

Read more
2 Oct 2009 15:33

ReNeuron boosted by study findings

Shares in stem cell developer ReNeuron were wanted after the company drew attention to the publication of new research using the company's ReNcell neural stem cell products. Researchers based in California have developed a safe strategy for reprogramming cells to a pluripotent (capable of affecting

Read more
17 Sep 2009 08:39

Small caps round-up: Byotrol, ReNeuron, Accuma...

Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30 to be ahead of expectations. Shares in Meridian Petroleum gushed higher after the oil and gas firm announced an increase in prospective resources in

Read more
8 Jul 2009 13:44

Sector movers: Astra lifts drug stocks after broker boost

Pharmaceutical stocks are higher after the broker Panmure Gordon said AstraZeneca was set to benefit from US rivals that produce generic alternatives to its cancer drug Casodex being too slow off the mark. AstraZeneca's slight rise is not as impressive as that of stem cell therapy developer ReNeuro

Read more
8 Jul 2009 10:55

Small caps round-up: Brainjuicer, ReNeuron, Hamworthy...

Market researcher BrainJuicer, whose clients include Unilever and Nike, posted revenue growth of about 22% for the first half and said it expects to make further progress in 2009. Stem cell therapy developer ReNeuron said clinical data on its lead CTX neural stem cell line in stroke and neurodegene

Read more
30 Jun 2009 09:00

Small caps round-up: MediaZest, Reneuron, Atlantic Coal...

Display advertising and screens provider Mediazest's pre-tax profits slide in the year as administrative expenses were too high, prompting the firm to undertake further cost cutting measures. The group also said first half of 2009 has seen a drop in activity as a consequence of the economic downt

Read more
9 Jun 2009 12:21

Angel rallies on ReNeuron deal

Angel Biotechnology rallied on news that the biopharmaceutical contract manufacturer signed a GMP manufacturing deal with ReNeuron. The value of the contract was not disclosed. The signing of deal follows on from ReNeuron's recent MHRA regulatory approval to commence a clinical trial with stem cell

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.